Specialist clinical reporting
-
-
‘Absolutely invaluable’, ‘Big-Brother like’: ARA initiative sparks controversy
The long road to RA immunotherapy
Podcast: Rheuma in the time of corona
The ongoing belimumab disappointment
Chronic pain could haunt some COVID survivors
Oz’s first wellness officer is a rheumatologist
What part 2 of the GiACTA trial means for Australia
APLAR interviews: RA treatment in 2030
APLAR interviews: Takayasu arteritis
APLAR interviews: Education *is* medicine
Guidelines for ME/CFS are outdated and dangerous
Let’s not overinterpret febuxostat study, author warns
Repeat ANA testing is useless, and Aussies have the data to prove it
-
ASCIA cautions against controversial peanut treatment
Award-winning trial changes pneumothorax treatment
Toxic degrading foam triggers recall of CPAP devices
Don’t prescribe steroids lightly: TSANZ
Electronic noses are not something to be sniffed atAI picks up first rumblings of thunderstorm asthma